Advertisement
Home2024-01-11T09:26:42-05:00

Top Story

Market Access

Advertisement

Featured Webinars

Handpicked Promotions & Highlights

Latest in Catalyst News powered by BioPharmCatalyst

04/17/2024 04:44 PM ET

Sage Therapeutics SAGE date announcement

Sage Therapeutics already had five catalyst announcements coming up, but they added another one today. On April 30, 2024, it will announce top-line results for their recent Phase 2 trial for Dalzanemdor (SAGE-718) - (PRECEDENT). [...]

Read More
04/17/2024 04:44 PM ET

TRACON Pharmaceuticals WINT earnings announcement

Windtree Therapeutics revealed their most recent quarterly earnings data for Q4. EPS was estimated to be -$0.94 and came in right around that value at -$0.95.

Closing price decreased significantly, falling $0.02 (-4.79%) to $0.40 [...]

Read More
04/17/2024 04:44 PM ET

Hepion Pharmaceuticals HEPA earnings announcement

Hepion Pharmaceuticals revealed their most recent quarterly earnings data, in which EPS ended up higher than estimates. EPS was estimated to be -$2.63 and the actual figure came in at -$2.42. Hepion Pharmaceuticals' EPS is [...]

Read More
04/17/2024 04:44 PM ET

NexImmune NEXI earnings announcement

NexImmune revealed their most recent quarterly earnings data for Q4. EPS was reported to be -$4.99.

The market was not pleased with the update. NexImmune decreased significantly, falling $0.32 (-9.22%) to $3.15 on light volume

Read More

Latest From Our Blog

Receive essential insights, resources and content direct to your inbox

Hit subscribe to stay informed!

Go to Top